Evicenter
MarkdownMedical informationP&T meetings
Deucrictibant (PHA121)

On-demand treatment of hereditary angioedema attacks

Also known as PHA-022121
Manufacturer
Pharvaris
Last updated
209 sources

Product information and disease descriptionProduct description

Product information

118 evidence topics · 49 sources

Average sales price and wholesale acquisition cost

Not applicable.

Effect of Deucrictibant on quality measures

No evidence found.